Search research articles
Contact Us
Filters
Showing results (211-220 of 257) with videos related to
Page
of 26
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 1, 1980
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin
R N Jones, P C Fuchs, A L Barry, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1994
In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa
J C McLaughlin, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1995
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years
S A Marshall, K E Aldridge, S D Allen, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1986
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates
R N Jones, P C Fuchs, A L Barry, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
June 14, 2008
Bioelectric impedance analysis and quality of life after body-contouring procedures in plastic surgery
R Smeets, E M Noah, N Y Seiferth, et al.
Diagnostic Microbiology and Infectious Disease
|
May 1, 1987
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria
P C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease
|
May 1, 1987
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid
A L Barry, T L Gavan, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1986
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria
P C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 1990
Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae
R N Jones, P C Fuchs, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease
|
April 1, 1986
In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agents
R N Jones, L W Ayers, A L Barry, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 257) with videos related to
Sort By:
Page
of 26
Antimicrobial Agents and Chemotherapy
|
April 1, 1980
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin
R N Jones, P C Fuchs, A L Barry, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1994
In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa
J C McLaughlin, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1995
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years
S A Marshall, K E Aldridge, S D Allen, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1986
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates
R N Jones, P C Fuchs, A L Barry, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
June 14, 2008
Bioelectric impedance analysis and quality of life after body-contouring procedures in plastic surgery
R Smeets, E M Noah, N Y Seiferth, et al.
Diagnostic Microbiology and Infectious Disease
|
May 1, 1987
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria
P C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease
|
May 1, 1987
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid
A L Barry, T L Gavan, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1986
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria
P C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 1990
Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae
R N Jones, P C Fuchs, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease
|
April 1, 1986
In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agents
R N Jones, L W Ayers, A L Barry, et al.
Page
of 26